Mass tort litigation in September 2026 is dominated by federal multidistrict litigation, not class actions: the Judicial Panel on Multidistrict Litigation counted 206,182 actions pending across 166 MDL dockets as of September 1, 2026. The year's two biggest developments cut in opposite directions — the Supreme Court gutted the core Roundup failure-to-warn theory in June, while Johnson & Johnson proposed a $5.5 billion resolution of the ovarian talc claims in July. This FAQ compares how the major dockets actually work and where each one stands. A mass tort is a group of individual injury claims against the same defendant, consolidated for pretrial handling — but each claim keeps its own value, its own proof, and its own outcome.
Table of Contents
- MDL or class action — which one is your case?
- Why did Roundup cases collapse in June 2026?
- Is the $5.5 billion talc settlement final?
- What a bellwether verdict does and does not tell you
- Where the other major dockets stand this month
- Three questions to ask before signing anything
- Frequently Asked Questions
MDL or class action — which one is your case?
A class action resolves everyone's claim in one judgment: you are a member unless you opt out, and you usually receive a formula-based share. An MDL does the opposite. Hundreds of thousands of separate lawsuits are transferred to one federal judge for discovery and pretrial rulings, then in theory returned to their home courts for trial. The numbers explain why this matters.
The JPML's September 1, 2026 docket report counted 206,182 pending actions out of 716,121 filed historically across all MDLs. Product-liability injury claims make up the bulk of that, and they are not certified classes. The practical consequence for a claimant: in an MDL, nobody settles your case without your agreement, and no single verdict decides your compensation. The trade-off is time — you wait for the common rulings that apply to everyone.
Why did Roundup cases collapse in June 2026?
On June 25, 2026, the Supreme Court decided *Monsanto Co. v. Durnell* 7-2, in an opinion by Justice Kavanaugh. The Court held that the Federal Insecticide, Fungicide, and Rodenticide Act — FIFRA, the federal pesticide labeling statute — expressly preempts a state-law failure-to-warn claim that would require a cancer warning on Roundup's EPA-approved label.
Failure to warn was the central theory in most glyphosate cases. Preemption means the federal labeling scheme displaces the state claim entirely, so the jury never reaches the science. You can read the full opinion on the Supreme Court's site. This is the clearest example of a risk every mass tort carries: a single legal ruling, unrelated to whether a product caused harm, can end tens of thousands of claims at once. Design-defect and other non-warning theories are a different question, and anyone with a pending Roundup claim should ask their lawyer specifically which theory their complaint pleads.
Is the $5.5 billion talc settlement final?
No. Johnson & Johnson announced on July 27, 2026 a proposed resolution of the ovarian talc litigation: a $5.5 billion commitment paid per qualifying claim, covering roughly 76,000 remaining claims, with a first payment of no more than $3 billion in 2027. The deal is conditioned on participation by at least 95% of those claims — below that threshold, it does not take effect. How the deal arose matters as much as its size.
According to J&J's Form 8-K filed the same day, the MDL court on July 22, 2026 ordered plaintiffs to show cause why remaining claims should not be dismissed, after they withdrew their specific-causation experts in two bellwether cases. The settlement followed a procedural collapse on the plaintiffs' side, not a defense loss at trial. "Paid per qualifying claim" is the phrase to read carefully. It is not a flat per-person figure: qualification criteria and claim tiering decide what any individual receives, and the 95% condition means the whole structure can still fail.
What a bellwether verdict does and does not tell you
A bellwether is a test case tried early in an MDL to show both sides what juries do with the evidence. In MDL 3084, the Uber sexual-assault litigation in the Northern District of California, the first bellwether, *Dean v. Uber Technologies*, returned an $8.5 million compensatory verdict on February 6, 2026, with no punitive damages.
The jury found the driver an apparent agent of Uber, rejecting the independent-contractor defense. Then the second bellwether, tried in North Carolina, returned roughly $5,000 — per Verus LLC's case-management analysis. Two verdicts in the same docket, three orders of magnitude apart. Use that spread as a filter when you read advertising or news coverage:.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
- A headline verdict is one jury's answer on one set of facts, not a settlement value.
- No bellwether verdict binds any other plaintiff in the MDL.
- Verdicts are often reduced or reversed on appeal before anyone is paid.
- Individual facts — injury severity, evidence quality, venue — drive the difference more than the defendant's identity.
Where the other major dockets stand this month
Hair relaxer (MDL 3060, N.D. Ill., Judge Rowland) sits at the general-causation stage — the threshold question of whether the product can cause the disease at all. Briefing closed June 16, 2026, and the defendants' Rule 702 motion to exclude plaintiffs' causation experts remains undecided as of September 2026, with roughly 11,371–11,779 cases pending and first trials expected in 2027. That ruling is the docket's pivot point; the talc experts' withdrawal shows what happens when causation proof fails. Depo-Provera (MDL 3140, N.D.
Fla., Judge Rodgers) moved faster. A tentative global settlement in June 2026 took the December 7, 2026 *Toney v. Pfizer* bellwether off the calendar and pushed the general-causation and preemption hearing to July 27, 2026, with roughly 6,294 cases pending as of the August 2026 JPML report. Camp Lejeune is not an MDL at all. It runs on the Camp Lejeune Justice Act, which requires an administrative claim to the Navy before suit. Per the Justice Department's program page and 2026 reporting, about 3,756 suits were filed in the Eastern District of North Carolina between February 11, 2023 and July 10, 2026, against roughly 408,500 de-duplicated administrative claims — with settlement offers above $968 million and payouts above $801 million as of mid-July 2026, and no bellwether trial yet completed.
Three questions to ask before signing anything
Mass tort advertising rarely distinguishes between a docket about to pay and one about to die. These questions separate them: One last practical point: with 206,182 actions pending across 166 dockets, a firm signing thousands of clients is not giving each one individual attention at intake. Ask who will actually work your file, and ask before you sign the retainer rather than after.
- **What stage is this docket in?** General causation undecided (hair relaxer) means the whole litigation could end on one ruling. A proposed settlement with a participation threshold (talc) means the structure exists but is conditional.
- **Which legal theory does my complaint plead?** *Durnell* killed failure-to-warn in Roundup while leaving other theories to fight another day. The theory, not the product, decides whether preemption reaches you.
- **Is there a filing deadline running separately?** Camp Lejeune claims move through an administrative process on statutory timing, not on MDL scheduling orders — the deadlines do not wait for a court calendar.
Frequently Asked Questions
Does the Roundup ruling affect other mass torts?
It affects any claim where a federal labeling statute governs the warning. *Durnell* turned on FIFRA specifically, which covers pesticides, so it does not automatically reach drug or device dockets — but it strengthens preemption arguments generally, including the preemption question still live in the Depo-Provera MDL.
If I am one of the 76,000 talc claimants, when would I be paid?
J&J's announcement sets a first payment of no more than $3 billion in 2027, and only if at least 95% of claims participate. Nothing is owed until that threshold is met.
Why has Camp Lejeune paid over $801 million without a single trial?
The statute routes claims through an administrative process at the Navy, where the government can settle directly. Those payouts come from that track, not from courtroom verdicts — which is why 408,500 claims have produced only about 3,756 filed suits.
What is a Rule 702 motion, and why does it decide cases?
Rule 702 governs whether expert testimony is reliable enough for a jury to hear. If a court excludes the plaintiffs' causation experts, the plaintiffs usually have no way to prove the product caused the injury, and the docket collapses without a trial.
You Might Also Like
- What Is New With Comparisons Mass Tort Litigation in September 2026? Latest court filings and agency notices and Key Takeaways
- Comparisons Mass Tort Litigation 2026 Guide: eligibility, causation, and deadlines; Key Facts and Questions to Ask
- Comparisons Mass Tort Litigation August 2026 Update: What Changed, Why It Matters, and What to Watch Next